Literature DB >> 7516152

Structural and functional characterization of elastases from horse neutrophils.

A Dubin1, J Potempa, J Travis.   

Abstract

In order better to understand the pathophysiology of the equine form of emphysema, two elastinolytic enzymes from horse neutrophils, referred to as proteinases 2A and 2B, have been extensively characterized and compared with the human neutrophil proteinases, proteinase-3 and elastase. Specificity studies using both the oxidized insulin B-chain and synthetic peptides revealed that cleavage of peptide bonds with P1 alanine or valine residues was preferred. Further characterization of the two horse elastases by N-terminal sequence and reactive-site analyses indicated that proteinases 2A and 2B have considerable sequence similarity to each other, to proteinase-3 from human neutrophils (proteinase 2A), to human neutrophil elastase (proteinase 2B) and to a lesser extent to pig pancreatic elastase. Horse and human elastases differed somewhat in their interaction with some natural protein proteinase inhibitors. For example, in contrast with its action on human neutrophil elastase, aprotinin did not inhibit either of the horse proteinases. However, the Val15, alpha-aminobutyric acid-15 (Abu15), alpha-aminovaleric acid-15 (Nva15) and Ala15 reactive-site variants of aprotinin were good inhibitors of proteinase 2B (Ki < 10(-9) M) but only weak inhibitors of proteinase 2A (Ki > 10(-7) M). In summary, despite these differences, the horse neutrophil elastases were found to resemble closely their human counterparts, thus implicating them in the pathological degradation of connective tissue in chronic lung diseases in the equine species.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516152      PMCID: PMC1138176          DOI: 10.1042/bj3000401

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Isolation and some molecular parameters of elastase-like normal proteinases from horse blood leucocytes.

Authors:  A Dubin; A Koj; J Chudzik
Journal:  Biochem J       Date:  1976-02-01       Impact factor: 3.857

2.  A simple computer program with statistical tests for the analysis of enzyme kinetics.

Authors:  S P Brooks
Journal:  Biotechniques       Date:  1992-12       Impact factor: 1.993

3.  Chronic pulmonary disease in the horse.

Authors:  H Gerger
Journal:  Equine Vet J       Date:  1973-01       Impact factor: 2.888

Review 4.  Chronic alveolar emphysema in the horse.

Authors:  J R Gillespie; W S Tyler
Journal:  Adv Vet Sci Comp Med       Date:  1969

5.  The specificity of purified porcine pancreatic elastase.

Authors:  A S Narayanan; R A Anwar
Journal:  Biochem J       Date:  1969-08       Impact factor: 3.857

6.  Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.

Authors:  J L Niles; R T McCluskey; M F Ahmad; M A Arnaout
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

7.  Human leukocyte granule elastase: rapid isolation and characterization.

Authors:  R J Baugh; J Travis
Journal:  Biochemistry       Date:  1976-02-24       Impact factor: 3.162

8.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

9.  Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells.

Authors:  D Bories; M C Raynal; D H Solomon; Z Darzynkiewicz; Y E Cayre
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

10.  Substrate specificity and modifications of the active centre of elastase-like neutral proteinases from horse blood leucocytes.

Authors:  A Koj; J Chudzik; A Dubin
Journal:  Biochem J       Date:  1976-02-01       Impact factor: 3.766

View more
  1 in total

Review 1.  Role of somatic cells on dairy processes and products: a review.

Authors:  N Li; R Richoux; M Boutinaud; P Martin; V Gagnaire
Journal:  Dairy Sci Technol       Date:  2014-07-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.